Acne Vulgaris – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Acne Vulgaris – Drugs In Development, 2024 report and make more profitable business decisions.
Acne vulgaris is a chronic skin disease involving blockage and inflammation of pilosebaceous follicles. Symptoms include crusting of skin bumps, cysts, papules (small red bumps), scarring of the skin, and redness around the skin eruptions. Risk factors include adolescence, hair gels or oil-based cosmetics, sports equipment such as helmet straps rubbing and occluding skin. Treatment includes antibiotics.
The Acne Vulgaris drugs in development market research report provide comprehensive information on the therapeutics under development for Acne Vulgaris, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acne Vulgaris and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Acne Vulgaris | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 62 molecules, with 60 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Acne Vulgaris therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Acne Vulgaris pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Acne Vulgaris treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
3SBio IncAkaal Pharma Pty Ltd
Almirall SA
AMD Therapeutics LLC
Amytrx Therapeutics Inc
AOBiome LLC
Arctic Therapeutics ehf
Arcutis Biotherapeutics Inc
Ascletis Pharma Inc
Atacama Therapeutics Inc
Attillaps Holdings Inc
Avecho Biotechnology Ltd
Avicanna Inc
Bausch Health Companies Inc
Biocidium Biopharmaceuticals Inc
Biofrontera AG
Biozeus Pharmaceutical SA
Boston Pharmaceuticals Inc
Botanix Pharmaceuticals Ltd
Claritas Pharmaceuticals Inc
Clinuvel Pharmaceuticals Ltd
Cosmo Pharmaceuticals NV
Cutia Therapeutics (HK) Ltd
Dermata Therapeutics Inc
DermaXon LLC
Eligo Bioscience SA
Galephar Pharmaceutical Research Inc
Hoth Therapeutics Inc
Innovation Pharmaceuticals Inc
Journey Medical Corp
Kintor Pharmaceutical Ltd
Lee's Pharmaceutical Holdings Ltd
Lipidio Pharmaceuticals Inc
Lipidor AB
Madam Therapeutics BV
Maruho Co Ltd
Matrisys Bioscience Inc
Mayne Pharma Group Ltd
Melinta Therapeutics LLC
Novan Inc
Novartis AG
Ortho Dermatologics Inc
Phagelux Inc
PHI Therapeutics Inc
Promius Pharma LLC
Revive Therapeutics Ltd
Riptide Bioscience Inc
Sanofi
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
Sinovant Sciences HK Ltd
Timber Pharmaceuticals Inc
Topaz Biosciences Inc
University of California Los Angeles
University of Saskatchewan
Vakona AB
Verge Therapeutics Inc
Vyome Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Acne Vulgaris reports